These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 19593085)

  • 21. Nonmyeloablative stem cell transplantation for chronic myeloid leukemia.
    Qazilbash MH; Giralt SA; Champlin RE
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):703-13, xi. PubMed ID: 15271401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nonmyeloablative stem cell transplantation as cancer immunotherapy].
    Willems E; Baron F; Vanstraelen G; Frère P; Fillet G; Beguin Y
    Rev Med Suisse; 2005 Aug; 1(30):1973-7. PubMed ID: 16200942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-myeloablative conditioning for hemopoietic stem cell transplantation--does it work?
    Cheong SK; Eow GI; Leong CF
    Malays J Pathol; 2002 Jun; 24(1):1-8. PubMed ID: 16329549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
    Maloney D
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S35-S36. PubMed ID: 18724296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonmyeloablative transplantation for solid tumors: a new frontier for allogeneic immunotherapy.
    Espinoza-Delgado I; Childs RW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):865-75. PubMed ID: 15485320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives.
    Ringdén O; Le Blanc K
    APMIS; 2005; 113(11-12):813-30. PubMed ID: 16480452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-myeloablative transplant of hematopoietic precursor cells. Myth and reality].
    Gómez-Almaguer D; Ruiz-Argüelles GJ; Gutiérrez-Aguirre CH; Jaime-Pérez JC
    Rev Invest Clin; 2005; 57(2):291-7. PubMed ID: 16524070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can reduced-intensity allogeneic transplantation cure older adults with AML?
    Storb R
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):85-90. PubMed ID: 17336258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation.
    Saito TI; Rubio MT; Sykes M
    Exp Hematol; 2006 Sep; 34(9):1271-7. PubMed ID: 16939820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allogeneic hematopoietic stem cell treatment after non-myeloablation (minigraft)].
    Baron F
    Bull Mem Acad R Med Belg; 2011; 166(1-2):39-45; discussion 46-8. PubMed ID: 22375489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
    Satwani P; Cooper N; Rao K; Veys P; Amrolia P
    Bone Marrow Transplant; 2008 Jan; 41(2):173-82. PubMed ID: 18037944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft engineering.
    Noga SJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):15-21. PubMed ID: 10877046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current indications for reduced-intensity allogeneic stem cell transplantation.
    Haddad N; Rowe JM
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):377-86. PubMed ID: 15498710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nonmyeloablative allogeneic hematopoietic stem cell transplantation: minitransplantation].
    Machaczka M; Rucińska M; Skotnicki AB
    Przegl Lek; 1999; 56(10):633-7. PubMed ID: 10695376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced-intensity conditioning regimens in malignant haematological diseases.
    Buffart TE; Janssen JJ; Huijgens PC
    Neth J Med; 2005 Feb; 63(2):43-51. PubMed ID: 15766008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning.
    Veelken H; Wäsch R; Behringer D; Bertz H; Finke J
    Bone Marrow Transplant; 2000 Oct; 26(8):911-5. PubMed ID: 11081395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current concepts in allogeneic hematopoietic stem cell transplantation.
    Tabbara IA; Kairouz S; Nahleh Z; Mihalcea AM
    Anticancer Res; 2003; 23(6D):5055-67. PubMed ID: 14981967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmyeloablative allogeneic stem cell transplantation for acute leukemia.
    Laport GG
    Curr Hematol Rep; 2003 Jan; 2(1):49-56. PubMed ID: 12901154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
    Handgretinger R; Kurtzberg J; Egeler RM
    Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.